It is with great pleasure we announce that Professor Sally Collins (Nuffield Department of Women’s & Reproductive Health) with the support of our Translational Research Office (Dr Deepak Kumar) and Oxford University Innovation (Dr Benedicte Menn) has been awarded the prestigious and highly competitive Sir Jules Thorn Translational Biomedical Research Award 2021. The last time this award was made to the University of Oxford was 10 years ago in 2011. Professor Collins receives just under £1 million by the charitable trust to further the translational development of the OxNNet Toolkit.
Professor Collins’ project aims to test the clinical performance of a robust, non-invasive, early screening test to identify babies at risk of adverse pregnancy outcomes through early detection of fetal growth restriction (FGR). FGR is the single greatest risk factor for stillbirth, a pregnancy outcome which is not only devastating for families but also costs the NHS >£12 million annually. This test aims to identify pregnancies at greatest risk of FGR, thereby appropriately targeting NHS resources to monitoring those pregnancies where timely delivery of the baby would prevent stillbirth and result in the greatest clinical benefit.